secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2022-11-28T23:59:59+00:00
Accession:  0001683168-22-008064
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals effects 1-for-30 reverse stock split to meet Nasdaq listing requirement
--------------------------------------------------------------------------------

- Reverse stock split effective Nov 28, 2022 at 4:01 PM ET; trading on split-adjusted basis begins Nov 29, 2022.
- Outstanding shares reduced from ~40.03M to ~1.33M; authorized shares remain at 75M.
- Purpose: increase per-share price to comply with Nasdaq minimum bid price requirement.
- No fractional shares; rounding up to whole share; CUSIP changes to 18978H201.
- Outstanding warrants, options, and RSUs adjusted proportionally; par value unchanged at $0.001.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316822008064/0001683168-22-008064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316822008064/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-008064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer